Today on DrugResearcher.com   Cheap drugs, no profit, just cures Caliper increases gene expression analysis throughput Pharmacopeia advances dual cardiovascular drug into Phase II FDA and Gene Logic to set genomic industry standards BioReliance launches new genotoxicity testing service

Related Industry News   All change at BioProgress Soma 250mg dose gets approval SAFC expands EU capacity, eyes more acquisitions Bayer, Novartis settle Betaseron battle

Breaking News on Drug Discovery
Daily  Monday 17 September 2007		Forward to a colleague

	Product Literature ClonePix FL - explore cell surfaces discover stellar clones ClonePix FL technology makes light-work of selecting and isolating mammalian cell clones by cell surface protein expression, rapidly yielding monoclonal populations for cell based assays, screening, downstream phenotyping/genotyping and basic discovery research... Click Here Access Full Stories Cheap drugs, no profit, just cures A group of leading drug developers have set up an international talent network for a 'global assault' on some of the world's deadliest diseases, such as tuberculosis (TB), malaria and AIDS, on a not-for-profit... Read Caliper increases gene expression analysis throughput Caliper Life Sciences has launched a new high throughput (HT) microfluidic assay that automates RNA quality and concentration assessment for gene expression analysis... Read Pharmacopeia advances dual cardiovascular drug into Phase II Pharmacopeia plans to expand the Phase I clinical study of its cardiovascular drug while beginning the next stage of trials, following promising results so far... Read FDA and Gene Logic to set genomic industry standards The FDA (US Food and Drug Administration) and Gene Logic are to collaborate in developing a set of industry standards for genomic data sent to the regulator... Read BioReliance launches new genotoxicity testing service Bioreliance has signed a deal with Gentronix to provide the UK firm's novel DNA damage testing tool as a service for biopharma companies for the first time... Read
	All News Headlines for: September | August | July
	Product Overview Have you got problems with aching hands in your lab? Lab professionals have twice as much upper limb disorders (URLD) as employees in general. The risk of Repetitive Strain Injury (RSI) increases, when pipetting over 1.5 hours/day. The strain will also have a negative impact on the accuracy and precision. Read more... Click Here
	Related Industry News All change at BioProgress UK tabletting specialist BioProgress made a series of announcements last week, not only landing itself a commercial partner and patent protection for its novel tablet coating technology, but also rebranding itself... Read Soma 250mg dose gets approval Swedish speciality pharma company Meda AB has announced its new low dose of Soma (carisoprodol) has been approved by the US Food and Drugs Administration (FDA)... Read SAFC expands EU capacity, eyes more acquisitions SAFC is investing $10m (€7.2m) to increase manufacturing capacity at its Ireland facility and to expand its Swiss plant, as well as eyeing two acquisitions in Europe, the company said last week. ... Read Bayer, Novartis settle Betaseron battle Novartis and Bayer Schering Pharma have finally settled their disputes over multiple sclerosis (MS) drug Betaseron (interferon beta-1b), with an agreement outlined in March now complete... Read Weekly Comment UK gets go-ahead for hybrid embryo research Eight months after the debate started over whether hybrid embryo research should be allowed in the UK, the HFEA has given researchers the thumbs up - but only on a case-by-case basis. Read Product Brochure A revolution in Sales Lead Generation! - Free Download Promote your products and technology towards our readers, and we'll build a detailed profile of each person who reads your presentation document... Download our FREE Smart Lead Generation brochure now!... Click Here Previous Headlines Novartis on NME trail Novartis is aiming to hunt down its rivals through a pipeline of truly innovative drugs, measured by increasing numbers of New Molecular Entities (NMEs) in development... Read Celsis jumps on ADME-Tox services bandwagon US-based pharma services firm Celsis International has announced the addition of ADME-Tox services to its portfolio thanks to a recent acquisition... Read New funding drive for 'Eurostars' The European Commission has named research-performing small and medium-sized enterprises (SMEs) as 'the entrepreneurial stars of Europe', and hopes to raise €800m of extra funds for them... Read Genomic data could alleviate health impact of loneliness Loneliness has been linked to serious diseases such as cancer, heart disease and infection but a new study could point to new ways of reducing its impact on health... Read ZS Genetics puts DNA under the microscope ZS Genetics has signed up outside academic assistance to speed up development of its 'revolutionary' microscopy-based genetic analysis technology platform... Read Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analysis and instrumentation Assays and screening Cell culture & Equipment Chromatography Compounds and consumables Contract services (outsourcing) Drug discovery Genomics / Proteomics Informatics & IT Lab equipment & consumables Liquid handling and automation Liquid handling and sample preparation Production technologies Separation and purification

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com